It is known that TROP2 modulates AKT signalling,28 which potentially supports glycolysis; However, whether CRC cells’ glycolytic activity directly responds to TROP2 expression and how it affects TROP2‐induced CRC metastatic behaviours remains unclear. This evidence concerns the gene TACSTD2 and colorectal carcinoma.